In sum, in the TME of CRC, the function of CD4+ T cells and the progression of CRC are affected by cholesterol metabolism, which regulates Th17 cell differentiation and iron metabolism, suggesting CD4+ T cells as possible therapeutic targets. The gene discussed is CD4; the disease is colorectal carcinoma.